Beam Therapeutics Inc. · NASDAQ:BEAM
The Vanguard Group's stake in Beam Therapeutics Inc. fell below 5% (Schedule 13G/A)
Event Mar 13, 2026 · Filed Mar 26, 2026
The Vanguard Group's stake in Beam Therapeutics Inc. fell below 5%, 0 shares, as a passive investor on Mar 13, 2026. Filed Mar 26, 2026 (Schedule 13G/A).
- Stake
- 0%
- Shares
- 0
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 0% | 0 |
Source
Related
- Beam Therapeutics Inc.
- The Vanguard Group
- Beam Therapeutics Inc. shareholders
- Form 4 · Evans John M. · Oct 16, 2026
- Form 4 · Cavanagh Bethany J · Oct 2, 2026
- Form 4 · Ciaramella Giuseppe · Sep 25, 2026
- Schedule 13G/A · ARK Investment Management LLC · Aug 14, 2026
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Aug 13, 2026